0000899243-22-036729.txt : 20221122
0000899243-22-036729.hdr.sgml : 20221122
20221122163516
ACCESSION NUMBER: 0000899243-22-036729
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221119
FILED AS OF DATE: 20221122
DATE AS OF CHANGE: 20221122
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kiboro Ali
CENTRAL INDEX KEY: 0001891241
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36415
FILM NUMBER: 221410926
MAIL ADDRESS:
STREET 1: C/O QUOTIENT LIMITED, B1
STREET 2: BUSINESS PARK TERRE BONNE
CITY: EYSINS
STATE: V8
ZIP: 1262
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Quotient Ltd
CENTRAL INDEX KEY: 0001596946
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 264719797
STATE OF INCORPORATION: Y9
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 28 ESPLANADE
CITY: SAINT HELIER
STATE: Y9
ZIP: JE2 3QA
BUSINESS PHONE: 41274832286
MAIL ADDRESS:
STREET 1: 28 ESPLANADE
CITY: SAINT HELIER
STATE: Y9
ZIP: JE2 3QA
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-11-19
0
0001596946
Quotient Ltd
QTNT
0001891241
Kiboro Ali
C/O QUOTIENT LIMITED, BUSINESS PARK
TERRE BONNE, ROUTE DE CRASSIER 13
EYSINS
V8
1262
SWITZERLAND
0
1
0
0
Chief Financial Officer
Ordinary Shares
2022-11-19
4
M
0
1526
A
3192
D
Restricted Stock Units
2022-11-19
4
M
0
1526
0.00
D
Ordinary Shares
1526
1526
D
Ordinary Share Option (Right to Buy)
83.20
2031-11-19
Ordinary Shares
3081
3081
D
Restricted Stock Units convert into ordinary shares on a one-for-one basis.
On November 19, 2021, the Reporting Person was granted 3,052 Restricted Stock Units, of which 1,526 have vested and converted into ordinary shares. The remaining 1,526 will vest in two equal annual installments on November 19, 2023 and November 19, 2024. The Restricted Stock Units were granted as an inducement grant pursuant to Nasdaq listing rule 5635(c)(4).
1,027 options vested on November 19, 2022 and remain exercisable, and the remaining 2,054 options will vest in two equal annual installments on November 19, 2023 and November 19, 2024. The option was granted as an inducement grant pursuant to Nasdaq listing rule 5635(c)(4).
/s/ Ali Kiboro
2022-11-22